| 產(chǎn)品名稱 | LY 2584702 tosylate |
| 產(chǎn)品貨號 | Axon 2464 CAS [1082949-68-5] MF C21H19F4N7.C7H8O3SMW 617.62 Purity: 98% Soluble in DMSO Description Oral, selective ATP-competitive inhibitor of p70 S6 kinase (S6K1; IC50 value 4 nM) with significant synergistic activity with Erlotinib (Axon 1128) and Everolimus. LY2584702 is selective against 83 other kinases as determined by a ubiquitin kinase panel, and 45 cell surface markers as determined by a CEREP mini panel. KEYWORDS:?LY 2584702 tosylate | supplier | S6K1 inhibitor | LY 2779964 | LY2584702 | LY2779964 | CAS [1082949-68-5] | [1082949-67-4] | (Ribosomal proteins) | p70-RSK | Inhibitor | p70S6K | PI3K | mTOR | Akt | ribosomal | cancer | Phase I | trial | ATP-competitive |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
LY 2584702 tosylateAxon 2464 CAS [1082949-68-5] MF C21H19F4N7.C7H8O3S
DescriptionOral, selective ATP-competitive inhibitor of p70 S6 kinase (S6K1; IC50 value 4 nM) with significant synergistic activity with Erlotinib (Axon 1128) and Everolimus. LY2584702 is selective against 83 other kinases as determined by a ubiquitin kinase panel, and 45 cell surface markers as determined by a CEREP mini panel. KEYWORDS:?LY 2584702 tosylate | supplier | S6K1 inhibitor | LY 2779964 | LY2584702 | LY2779964 | CAS [1082949-68-5] | [1082949-67-4] | (Ribosomal proteins) | p70-RSK | Inhibitor | p70S6K | PI3K | mTOR | Akt | ribosomal | cancer | Phase I | trial | ATP-competitive
Oral, selective ATP-competitive inhibitor of p70 S6 kinase (S6K1)
Chemical name4-(4-(4-(4-fluoro-3-(trifluoromethyl)phenyl)-1-methyl-1H-imidazol-2-yl)piperidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidine 4-methylbenzenesulfonate Parent CAS No.[1082949-67-4] |
| 產(chǎn)品資料 |
